IFN-alpha D Protein
-
- Target
- IFN-alpha D (IFNAD) (Interferon-alpha-D (IFNAD))
- Protein Type
- Recombinant
- Biological Activity
- Active
- Origin
- Human
- Source
- Escherichia coli (E. coli)
- Characteristics
-
Purified recombinant Human IFN alpha D protein
Expression System: E.coli
Bioactivity: The EC50 for interferon in a cytopathic effect inhibition assay is ~1 U/mL (Human) and ~5 U/mL (Bovine) - Purity
- > 95 % pure
- Endotoxin Level
- < 1 EU/µg
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 10000000 U/mL
- Buffer
- Supplied as a liquid in PBS with 0.1 % BSA.
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -80 °C
-
- Target
- IFN-alpha D (IFNAD) (Interferon-alpha-D (IFNAD))
- Alternative Name
- IFN alpha D
- Synonyms
- interferon-alpha-D Protein, IFNAD Protein
- Background
-
Interferon alpha A and D are produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. Interferon-Alpha A/D Bg/II is an alpha interferon hybrid that crosses the species barrier. The Bg/II denotes the restriction enzyme site from which this hybrid is constructed from recombinant human interferons Alpha A and Alpha D. Interferon-Alpha A/D has been proven to be active on many mammalian cells. It can substitute for human, monkey, mouse, bovine, rat, cat, dog, rabbit, sheep, goat, horse, pig or hamster type I interferon (alpha, beta, omega and tau).
Alternative Names: Interferon alpha D protein - Molecular Weight
- 19.4 kDa
-